Comparison of EBV DNA viral load in whole blood, plasma, B-cells and B-cell culture supernatant.
J Med Virol
; 86(5): 851-6, 2014 May.
Article
em En
| MEDLINE
| ID: mdl-24265067
ABSTRACT
Epstein-Barr virus (EBV) genome quantitation in whole blood is used widely for therapeutic monitoring of EBV-associated disorders in immunosuppressed individuals and in patients with EBV-associated lymphoma. However, the most appropriate biological material to be used for EBV DNA quantitation remains a subject of debate. This study compare the detection rate and levels of EBV DNA from whole blood, plasma, enriched B-cells, and B-cell short-term culture supernatant using quantitative real-time PCR. Samples were collected from 33 subjects with either HIV infection or B-cell lymphoma. Overall, EBV DNA was detected in 100% of enriched B-cell samples, in 82% of B-cell culture supernatants, in 57% of plasma, and 42% of whole blood samples. A significant correlation for EBV viral load was found between enriched B-cell and B-cell culture supernatant material (ρ = 0.92; P < 0.0001), but no significant correlation existed between EBV DNA levels in whole blood and enriched B-cells (ρ = -0.02; P = 0.89), whole blood and plasma (ρ = 0.24; P = 0.24), or enriched B-cells and plasma (ρ = 0.08; P = 0.77). Testing of enriched B-cells appeared to be the most sensitive method for detection of EBV DNA as well as for exploration of the cellular reservoir. Quantitation of EBV DNA in plasma and B-cell culture supernatant may be of interest to assess EBV reactivation dynamics and response to treatment as well as to decipher EBV host-pathogen interactions in various clinical scenarios.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Sangue
/
DNA Viral
/
Linfócitos B
/
Carga Viral
/
Técnicas de Laboratório Clínico
/
Infecções por Vírus Epstein-Barr
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article